Congenital distal spinal muscular atrophy
Congenital Distal Spinal Muscular Atrophy (CDSMA) is a rare neuromuscular disorder characterized by progressive muscle weakness and atrophy. It is a subtype of Spinal Muscular Atrophy (SMA), a group of hereditary diseases that cause weakness and wasting of the voluntary muscles in the arms and legs of infants and children.
Etiology[edit | edit source]
CDSMA is caused by mutations in the TRPV4 gene. This gene provides instructions for making a protein that is involved in various cellular functions, including the regulation of ion channels. Mutations in the TRPV4 gene disrupt the function of the protein, leading to the death of nerve cells in the spinal cord that control muscle movement.
Clinical Features[edit | edit source]
The symptoms of CDSMA typically appear at birth or in early infancy. They include weakness and wasting (atrophy) of the muscles of the lower limbs (distal muscles), particularly the muscles of the feet and hands. As the disease progresses, the weakness and atrophy may spread to other muscles of the body. Other features may include joint deformities (contractures), abnormalities of the spine (scoliosis), and respiratory problems.
Diagnosis[edit | edit source]
The diagnosis of CDSMA is based on the clinical symptoms, a detailed patient history, and specialized tests. These tests may include a nerve conduction study (NCS), electromyography (EMG), and genetic testing to identify mutations in the TRPV4 gene.
Treatment[edit | edit source]
There is currently no cure for CDSMA. Treatment is supportive and aims to improve the quality of life for individuals with the disorder. This may include physical therapy, occupational therapy, and the use of assistive devices to help with mobility. In some cases, surgery may be necessary to manage complications such as scoliosis.
Prognosis[edit | edit source]
The prognosis for individuals with CDSMA varies. Some individuals may have a normal life expectancy, while others may experience severe complications that can be life-threatening.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
